VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
VivoSim Labs, Inc. (VIVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 3.70 thousand shares for the 3-month period ending 2013-12-31, per its 10-Q filed 2014-02-06.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2014-02-06
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2013-12-31 was 3.70K shares, a 58.95% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2013-09-30 was 160.54K shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2012-12-31 was 9.02K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 month |
|---|---|---|---|
| 2013-12-31 | 3.70K shares 10-Q · filed 2014-02-06 | 164.24K shares derived: sum of 2 quarters · filed 2014-02-06 | 164.24K shares 10-Q · filed 2014-02-06 |
| 2013-09-30 | 160.54K shares 10-Q · filed 2013-11-08 | ||
| 2012-12-31 | 9.02K shares 10-Q · filed 2014-02-06 | 89.67K shares 10-Q · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |